Ignite Creation Date:
2025-12-24 @ 11:57 PM
Ignite Modification Date:
2025-12-25 @ 9:54 PM
Study NCT ID:
NCT00634751
Status:
COMPLETED
Last Update Posted:
2019-11-26
First Post:
2008-03-05
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
CO07204-Phase I/II of Oxaliplatin, Capecitabine & Sorafenib for Advanced Pancreatic & Biliary Carcinoma
Sponsor:
University of Wisconsin, Madison
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-02
Start Date Type:
None
Primary Completion Date:
2010-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-07
Completion Date Type:
ACTUAL
First Submit Date:
2008-03-05
First Submit QC Date:
None
Study First Post Date:
2008-03-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-06-12
Results First Submit QC Date:
None
Results First Post Date:
2017-08-08
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-11-14
Last Update Post Date:
2019-11-26
Last Update Post Date Type:
ACTUAL